Colt CZ Group (CZG) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
20 Nov, 2025Executive summary
Revenues for 9M 2025 reached CZK 16.1bn, up 7.3% year-over-year, with adjusted EBITDA at CZK 3.4bn, up 13.6% year-over-year, and adjusted net profit at CZK 1.45bn, up 11.8% year-over-year.
Net profit rose to CZK 1.33bn from CZK 709m year-over-year, with comprehensive income reaching CZK 1.47bn.
Margin improvement was primarily driven by acquisition effects, notably the Sellier & Bellot (S&B) acquisition.
Major events included the acquisition of Valley Steel Stamp Inc., a new share buyback program, and a dividend payout of CZK 15 per share.
The ammunition segment showed strong profitability despite softness in the US commercial market, while the firearms segment was impacted by a US market slowdown and a six-week US federal government shutdown.
Financial highlights
Adjusted EPS for 9M 2025 was CZK 25.6, down 11.6% year-over-year, mainly due to S&B acquisition-related amortization.
Net profit for 9M 2025 was CZK 1.33bn, up from CZK 709m in 9M 2024.
Operating profit increased to CZK 2.27bn from CZK 1.24bn year-over-year.
Cash flow from operating activities was CZK 3.19bn, up from CZK 1.41bn year-over-year.
Total assets stood at CZK 46.7bn as of 30 September 2025, with equity of CZK 20.7bn.
Outlook and guidance
Revised 2025 revenue guidance is CZK 23–24.5bn and EBITDA guidance is CZK 4.5–4.8bn, reflecting the impact of the US government shutdown.
Q4 2025 is expected to be the strongest quarter, with revenues projected at CZK 7–8.5bn and adjusted EBITDA at CZK 1.1–1.4bn.
Proceeds from a CZK 6bn bond issue in November 2025 will support CAPEX, working capital, M&A, and general corporate purposes.
The company is expanding its presence in Ukraine with a new representative office.
Latest events from Colt CZ Group
- Net profit surged as ammunition growth offset U.S. firearms weakness; 2026 set for major gains.CZG
Q4 202525 Mar 2026 - Ammunition-led growth and acquisitions drove higher revenues, with 2025 outlook reaffirmed.CZG
Q2 202518 Sep 2025 - Revenue up 51%, but net profit down on acquisition costs; guidance and leverage targets met.CZG
Q3 202413 Jun 2025 - Record H1 2024 revenue and EBITDA growth driven by Sellier & Bellot acquisition and US recovery.CZG
Q2 202413 Jun 2025 - Q1 2025 revenue up 50% and profit up 73%, with U.S. tariffs posing EBITDA risk.CZG
Q1 20259 Jun 2025 - 2024 revenue up 50.6% to CZK 22.4bn, with 2025 growth and profit distribution split expected.CZG
Q4 20249 Jun 2025